Literature DB >> 4723799

Effect of probenecid on the excretion of ampicillin in human bile.

J Kampmann, F Lindahl, J M Hansen, K Siersbaek-Nielsen.   

Abstract

1. Ampicillin concentrations were determined in serum and bile after intravenous injection into patients with T-tube bile drainage of 1 gram ampicillin before and during probenecid medication. The concentrations were followed up to fifteen hours after injection.2. Probenecid increased the half-life of ampicillin in serum from 74 minutes to 137 minutes.3. Ampicillin concentrations in bile were higher following probenecid medication and a concentration over 5 mug/ml was obtained for 3 h longer than before probenecid.4. The ampicillin concentrations in bile were approximately the same as those in serum both before and during probenecid medication suggesting passive transport of ampicillin from blood to bile.5. A combined treatment of ampicillin and probenecid might be of clinical value in the therapy of cholangitis and typhoid carriers.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4723799      PMCID: PMC1776070          DOI: 10.1111/j.1476-5381.1973.tb08205.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  4 in total

1.  AMPICILLIN LEVELS IN HUMAN BILE.

Authors:  G A AYLIFFE; A DAVIES
Journal:  Br J Pharmacol Chemother       Date:  1965-02

2.  Ampicillin activity in vitro and absorption and excretion in normal young men.

Authors:  J O KLEIN; M FINLAND
Journal:  Am J Med Sci       Date:  1963-05       Impact factor: 2.378

3.  Treatment of chronic typhoid carriers with ampicillin.

Authors:  W E Phillips
Journal:  JAMA       Date:  1971-08-16       Impact factor: 56.272

4.  Ampicillin levels in human bile in the presence of biliary tract disease.

Authors:  P R Mortimer; D B Mackie; S Haynes
Journal:  Br Med J       Date:  1969-07-12
  4 in total
  7 in total

1.  Serum concentrations of ampicillin and probenecid and ampicillin excretion after repeated oral administration of a pivampicillin-probenecid salt (MK-356).

Authors:  H G Kampffmeyer; I Hartmann; H Metz; G O Breault; H R Skeggs; A E Till; L Weidner
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

Review 2.  Pharmacokinetics of the penicillins in man.

Authors:  M Barza; L Weinstein
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

3.  Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation.

Authors:  J P Kampmann; H Klein; B Lumholtz; J E Mølholm Hansen
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

4.  The effect of probenecid on paracetamol metabolism and pharmacokinetics.

Authors:  F Kamali
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal.

Authors:  J I Macdonald; S M Wallace; R J Herman; R K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

6.  Ampicillin in portal and peripheral blood and bile after oral administration of ampicillin and pivampicillin.

Authors:  B Lund; C Mogensen; J Molholm-Hansen; J Kampmann; K Siersbaek-Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

7.  Pharmacokinetics of sulbactam in humans.

Authors:  G Foulds; J P Stankewich; D C Marshall; M M O'Brien; S L Hayes; D J Weidler; F G McMahon
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.